Article
PARP inhibition promotes endothelial-like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry.
The Journal of pathology - 1 Mar 2023
Fernández-Cortés Mónica, Delgado-Bellido Daniel, Bermúdez-Jiménez Eloísa, Paramio Jesús M, O'Valle Francisco, Vinckier Stefan, Carmeliet Peter, Garcia-Diaz Angel, Oliver F Javier
Abstract excerpt
Vasculogenic mimicry (VM) describes the ability of highly aggressive tumor cells to develop pseudovascular structures without the participation of endothelial cells. PARP1 is implicated in the activation of hypoxia-inducible factors, which are crucial in tumor neovascularization. We have explored the role of hypoxia and PARP inhibition in VM. In uveal melanoma xenografts, the PARP inhibitor olaparib improved in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
